HEC-921为公司自主研发的双特异性抗体药物，拟用于治疗晚期实体瘤，以LY6G6D阳性结直肠癌为主要开发方向。 HEC-921通过肿瘤靶向依赖的免疫激活设计，利用LY6G6D靶点实现肿瘤组织特异性富集，同时通过4-1BB通路在肿瘤微环境中进行区域性免疫激活，发挥抗肿瘤作用。

If you are having difficulty accessing any content on this website, please visit our Accessibility page.

Saudi ‌Aramco resumed oil loading on Friday at its Ras Tanura terminal in the Gulf after a near four-month halt, shipping data from LSEG showed, in ⁠a sign that Middle Eastern producers are pushing ...

SINGAPORE, June 26 (Reuters) - Saudi Aramco resumed crude loadings on Friday at its Ras Tanura terminal in the Gulf after a near four-month halt, shipping data showed, as the world's biggest oil ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...